Akso Health (AHG) Equity Average (2022 - 2025)

Akso Health has reported Equity Average for 4 years, with the latest figure at $198.7 million in Q3 2025.

• For the quarter ending Q3 2025, Equity Average rose 17.22% year-over-year to $198.7 million; the trailing twelve-month figure through Sep 2025 stood at $198.7 million (up 17.22% YoY), and the FY2025 full-year result was $168.8 million, up 129.23% from the prior year.
• Equity Average for Q3 2025 stood at $198.7 million, down from $199.9 million in the prior quarter.
• The five-year high for Equity Average was $199.9 million in Q1 2025, with the low at $7.1 million in Q3 2023.
• Historically, Equity Average has averaged $95.4 million across 4 years, with a median of $71.9 million in 2024.
• Annual changes were most pronounced in 2023 — Equity Average sank 36.21% — and 2024, when it surged 2292.75%.
• Akso Health's Equity Average stood at $11.1 million in 2022, then slumped by 36.21% to $7.1 million in 2023, then surged by 2292.75% to $169.5 million in 2024, then grew by 17.22% to $198.7 million in 2025.
• The last three Equity Average figures came in at $198.7 million (Q3 2025), $199.9 million (Q1 2025), and $169.5 million (Q3 2024), per Business Quant data.